| Advate 250 IU/5 ml powder and solvent for solution for injection EU/1/03/271/001 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 3000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/006 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 500 IU/2 ml powder and solvent for solution for injection EU/1/03/271/008 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 500 IU/5 ml powder and solvent for solution for injection EU/1/03/271/002 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advil Cold & Flu Coated Tablets Ibuprofen 200mg Pseudoephedrine Hydrochloride 30mg PA0678/147/001 |
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE |
Haleon Ireland Limited |
Marketed |
| Advil Cold & Flu Relief Soft Capsules Ibuprofen 200mg Pseudoephedrine Hydrochloride 30mg PA0678/147/002 |
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE |
Haleon Ireland Limited |
Not marketed |
| ADYNOVI 1000 IU Powder and solvent for solution for injection EU/1/17/1247/010-012 |
Rurioctocog alfa pegol |
Baxalta Innovations GmbH |
— |
| ADYNOVI 2000 IU Powder and solvent for solution for injection EU/1/17/1247/013-014 |
Rurioctocog alfa pegol |
Baxalta Innovations GmbH |
— |
| ADYNOVI 250 IU Powder and solvent for solution for injection EU/1/17/1247/001-004 |
Rurioctocog alfa pegol |
Baxalta Innovations GmbH |
— |
| ADYNOVI 3000 IU Powder and solvent for solution for injection EU/1/17/1247/015-016 |
Rurioctocog alfa pegol |
Baxalta Innovations GmbH |
— |
| ADYNOVI 500 IU Powder and solvent for solution for injection EU/1/17/1247/005-008 |
Rurioctocog alfa pegol |
Baxalta Innovations GmbH |
— |
| ADZYNMA 1500 IU powder and solvent for solution for injection EU/1/24/1837/002 |
Apadamtase alfa |
Takeda Manufacturing Austria AG |
— |
| ADZYNMA 500 IU powder and solvent for solution for injection EU/1/24/1837/001 |
Apadamtase alfa |
Takeda Manufacturing Austria AG |
— |
| Aerinaze 2.5 mg/120 mg modified-release tablets EU/1/07/399/001-006 |
Pseudoephedrine sulfate, Desloratadine |
N.V. Organon |
— |
| Aerius 0.5 mg/ml oral solution EU/1/00/160/61-69 |
Desloratadine |
N.V. Organon |
— |
| Aerius 5 mg film-coated tablets EU/1/00/160/001-013 |
Desloratadine |
N.V. Organon |
— |
| Afinitor 10 mg Tablet EU/1/09/538/004 |
Everolimus |
Novartis Europharm Limited |
— |
| Afinitor 2.5 mg Tablet EU/1/09/538/009-010 |
Rad n bht |
Novartis Europharm Limited |
— |
| Afinitor 5 mg Tablet EU/1/09/538/001 |
Everolimus |
Novartis Europharm Limited |
— |
| AFLUNOV suspension for injection in pre-filled syringe EU/1/10/658/001-002 |
H5n1 (a/vietnam/1194/2004) |
Seqirus S.r.l. |
— |
| Afqlir EU/1/24/1867/001 |
Aflibercept |
Sandoz GmbH |
— |
| Afqlir EU/1/24/1867/002 |
Aflibercept |
Sandoz GmbH |
— |
| AFSTYLA 1000 IU powder and solvent for solution for injection EU/1/16/1158/003 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 1500 IU powder and solvent for solution for injection EU/1/16/1158/004 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 2000 IU powder and solvent for solution for injection EU/1/16/1158/005 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 250 IU powder and solvent for solution for injection EU/1/16/1158/001 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 2500 IU powder and solvent for solution for injection EU/1/16/1158/006 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 3000 IU powder and solvent for solution for injection EU/1/16/1158/007 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 500 IU powder and solvent for solution for injection EU/1/16/1158/002 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AGAMREE 40 mg/ml oral suspension EU/1/23/1776/001 |
Vamorolone |
Santhera Pharmaceuticals (Deutschland) GmbH |
— |
| Agilus 120 mg powder for solution for injection EU/1/24/1805/001-002 |
Dantrolene Sodium, Hemiheptahydrate |
Norgine B.V. |
— |
| Ahzantive 40 mg/ml Solution for injection EU/1/24/1888/001 |
Aflibercept |
Formycon AG |
— |
| Aimovig 140 mg Solution for injection EU/1/18/1293/004-006 |
ERENUMAB |
Novartis Pharma GmbH |
— |
| Aimovig 70 mg Solution for injection EU/1/18/1293/001-003 |
ERENUMAB |
Novartis Europharm Limited |
— |
| AJOVY 225 mg Solution for injection EU/1/19/1358/001-002 |
FREMANEZUMAB |
TEVA GmbH |
— |
| AKANTIOR 0.8 mg/mL eye drops, solution in single-dose container EU/1/24/1840/001-003 |
Polihexanide |
SIFI S.p.A. |
— |
| Akeega 100mg/500 mg Film-coated tablet EU/1/23/1722/002 |
Niraparib Tosilate Monohydrate, Abiraterone acetate |
Janssen-Cilag International NV |
— |
| Akeega 50 mg/500 mg Film-coated tablet EU/1/23/1722/001 |
Niraparib Tosilate Monohydrate, Abiraterone acetate |
Janssen-Cilag International NV |
— |
| Akineton 2 mg tablets PA1253/001/001 |
Biperiden hydrochloride |
Laboratorio Farmaceutico S.I.T. |
Marketed |
| Akineton Retard 4 mg prolonged release tablets PA1253/002/001 |
Biperiden hydrochloride |
Laboratorio Farmaceutico S.I.T. |
Marketed |
| Akynzeo 235 mg/0.25 mg concentrate for solution for infusion EU/1/15/1001/004 |
FOSNETUPITANT CHLORIDE HYDROCHLORIDE, Palonosetron hydrochloride |
Helsinn Birex Pharmaceuticals Limited |
— |
| Akynzeo 235 mg/0.25 mg powder for concentrate for solution for infusion EU/1/15/1001/003 |
FOSNETUPITANT CHLORIDE HYDROCHLORIDE, Palonosetron hydrochloride |
Helsinn Birex Pharmaceuticals Limited |
— |
| Akynzeo 300 mg/0.5 mg hard capsules EU/1/15/1001/001 |
Netupitant, Palonosetron (as hydrochloride) |
Helsinn Birex Pharmaceuticals Limited |
— |
| Aldara 5% w/w Cream EU/1/98/080/001 |
Imiquimod |
Viatris Healthcare Limited |
— |
| Aldurazyme 100 U/ml concentrate for solution for infusion EU/1/03/253/01-3 |
Laronidase |
Sanofi B.V. |
— |
| Alecensa 150 mg hard capsules EU/1/16/1169/001 |
Alectinib hydrochloride |
Roche Registration GmbH |
— |
| Alendronic Acid Bluefish Once weekly 70 mg tablets PA1436/004/001 |
Sodium alendronate |
Bluefish Pharmaceuticals AB |
Marketed |
| Alhemo 15 mg/1.5 mL solution for injection in pre-filled pen EU/1/24/1881/001-002 |
Concizumab |
Novo Nordisk A/S |
— |
| Alhemo 150 mg/1.5 mL solution for injection in pre-filled pen EU/1/24/1881/005-006 |
Concizumab |
Novo Nordisk A/S |
— |
| Alhemo 300 mg/3 mL solution for injection in pre-filled pen EU/1/24/1881/007 |
Concizumab |
Novo Nordisk A/S |
— |